How herpes wakes up

A tiny piece of viral RNA is key to reactivating the dormant infection.

Honing their abilities for millions of years, herpesviruses are the Wolverine of human viruses: the best there is at what it does. 

Nearly universal in humans in at least one of its varieties, it is almost a certainty that some variety of herpesvirus is lurking inside you right now, slumbering in your cells. 

The laundry list of maladies they cause — chickenpox, cold sores, genital herpes, mononucleosis, shingles, infant rashes — don’t only occur during the initial infection, but also when they reawaken and begin replicating again. 

Herpesvirus can hide in neurons, out of reach of the immune system, waiting to wake up.

Then, damage done, they slip back into hiding inside your neurons, out of reach of the immune system, and wait to mysteriously reemerge again.

Researchers from Germany’s Julius-Maximilians-Universität Würzburg believe they have identified how one kind of herpesvirus wakes itself up again, using a tiny piece of viral RNA called a microRNA to reactivate itself and smother the counteracting immune response.

The work not only takes a step closer to understand how herpes wakes up, but may also provide us new ways to treat it — perhaps by using artificial microRNAs to fight back against the viruses

Full of tricks: After herpes infects a person, it hides out in the cells of your nervous system. (Uniquely, the virus does this by stealing a little molecular “engine” from your own cells to break into neurons.)

Because of this hiding ability, herpesvirus can be constrained, but never eliminated. It may reawaken and cause symptoms like cold sores or shingles, before the immune system and/or antivirals drive it back into hiding.

But how exactly it wakes up has remained an open question — and so there is no known way to prevent it.

“How herpesviruses reactivate from a dormant state is the central question in herpesvirus research,” JMU virologist Lars Dölken said in a statement. “If we understand this, we know how to intervene therapeutically.”

“How herpesviruses reactivate from a dormant state is the central question in herpesvirus research.”

Lars Dölken

A little key: For their study, published in Nature, the researchers looked at human herpesvirus 6A (HHV-6A). 

HHV-6A’s sibling, HHV-6B, is present in nearly 100% of people, causing a mild but very contagious childhood rash called roseola. While less is known about the prevalence of HHV-6A, small studies suggest it is present around half of adults. 

HHV-6A’s reawakening has been tied to impaired heart function, organ rejection, and possibly diseases of the nervous system, according to JMU. (There is even some evidence that HHV-6 and HHV-7 reawakening in the brain may contribute to Alzheimer’s.)

The researchers found that HHV-6A wakes up using microRNA (miRNA). Herpesviruses use miRNAs to reprogram the cells they infect, turning them to their own uses.

This particular virus wakes up and begins replicating again using one miRNA in particular, called miR-aU14, as the trigger. 

A piece of viral microRNA wakes up the virus and suppresses the immune system, allowing it to go from cell-chilling to cell-killing.

The virus makes the miRNA itself, and as soon as it is released into the cell, it begins to mess with our own microRNA. This makes the cell’s mitochondria split into lots of little organelles. With their mitochondria compromised, the cells stop producing important chemical signals, called type 1 interferons, which work like an alarm telling the immune system that a virus has invaded. 

With the cell’s distress signals shut down, the virus can go from “latent to lytic” — or, as I call it, “cell-chilling to cell-killing” — and replicate like crazy without the immune system stopping it. 

The researchers believe that targeting this miRNA may provide new ways to treat herpesvirus, like preventing it from ever awakening again — perhaps similar to how antiretroviral therapy holds down HIV — or waking it up on purpose, flushing it into the open for the immune system to attack it. 

But to do that, they will need to better understand how that same miRNA serves as the trigger for the virus to wake up — which remains a mystery.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected]

New nasal spray aimed at reversing fentanyl overdoses is now approved
A new overdose-reversing spray that works fast but lasts longer has been approved by the FDA, and will be available by the fall at earliest.
Do we finally know what causes Alzheimer’s?
The first treatments proven to slow cognitive decline in Alzheimer’s are helping settle a decades-long debate about how the disease starts.
This “bridge” between chemo and cancer solves a big problem for treatment
To improve leukemia treatment, Australian researchers have created a bispecific antibody that connects chemo drugs to cancer cells.
Pill version of obesity drug reduced weight almost 13% in new trial
Novo Nordisk has announced positive results for an oral version of the popular weight loss drug sold as Ozempic and Wegovy.
Cancer treatment is about to get a reboot, thanks to AI
Techniques borrowed from astrophysics are helping to advance personalized cancer treatments beyond what genetics can tell us.
Up Next
Subscribe to Freethink for more great stories